A pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus granulocyte colony stimulating factor as adjuvant therapy in early breast cancer-Reference-Cited by-同舟云学术

A pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus granulocyte colony stimulating factor as adjuvant therapy in early breast cancer

Published:1994-01 Issue:5 Volume:30 Page:606-610
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Del Mastro L.,Garrone O.,Sertoli M.R.,Canavese G.,Catturich A.,Guenzi M.,Rosso R.,Venturini M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. Dose-response effect of adjuvant chemotherapy in breast cancer;Bonadonna;N Engl J Med,1981

2. Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer;Hryniuk;J Clin Oncol,1986

3. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer;Crawford;New Engl J Med,1991

4. Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy;Trillet-Lenoir;Eur J Cancer,1993

5. Effects of recombinant human granulocyte-macrophage colony stimulating factor on myelosuppression induced by multiple cycles of high-dose chemotherapy in patients with advanced breast cancer;Hoekman;J Natl Canc Inst,1991

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose-Dense Adjuvant Chemotherapy in Early Breast Cancer Patients: Results From a Randomized Trial;JNCI: Journal of the National Cancer Institute;2005-12-07

2. Objective Response to Chemotherapy As a Potential Surrogate End Point of Survival in Metastatic Breast Cancer Patients;Journal of Clinical Oncology;2005-08-01

3. Chemotherapy;Classic Papers in Breast Disease;2004-01-04

4. The Role of Anthracyclines/Anthraquinones in Metastatic Breast Cancer;Breast Cancer Research and Treatment;2003-03

5. Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimens;Bone Marrow Transplantation;2002-06